JENNIFER FOSDICK: Open Payments
NPI 1619256955 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 36 payments from 13 companies in 2025. Trend: 2023 $665 · 2024 $1,513 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 7 | $173 |
| ViiV Healthcare Company | 7 | $157 |
| ABBVIE INC. | 6 | $129 |
| Novo Nordisk Inc | 4 | $82 |
| Neurocrine BioSciences, Inc. | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| Theratechnologies Inc. | 1 | $29 |
| EMD Serono, Inc. | 1 | $25 |
| Napo Pharmaceuticals Inc | 1 | $24 |
Products named: VRAYLAR, APRETUDE, Rybelsus, INGREZZA, DOVATO, AIRSUPRA, MAVYRET, CABENUVA.
Industry payments across FL — which companies pay providers there.
